Target intelligence / Profile preview

Chromatin accessibility complex protein 1 (CHRAC1)

Target
CHRAC1
Molecular classification
Chromatin remodeling factor, Histone-fold protein, Accessory subunit of ATP-dependent chromatin remodeling complex
01

Overview

Chromatin accessibility complex protein 1 (CHRAC1) is a histone-fold protein that functions as an accessory subunit of ATP-dependent chromatin remodeling complexes, such as those involving ISWI/SNF2H and ACF1. CHRAC1 interacts with other histone-fold proteins to form dimers, binding DNA in a sequence-independent manner, and is essential for DNA transcription, replication, and chromatin packaging. Within larger chromatin remodeling complexes, it modulates nucleosome positioning and chromatin accessibility to influence gene expression. In cancer, CHRAC1 overexpression drives cell proliferation and survival, notably by interacting with the transcriptional coactivator YAP in the Hippo signaling pathway, thereby promoting oncogenic transcriptional programs. Its dysregulation is implicated in several cancer types and developmental disorders, indicating both its physiological importance and therapeutic potential[1][2][3][4].

Other names
CHRAC-15CHRAC15CHARC15CHRAC-1YCL1CHARC1DNA polymerase epsilon subunit p15histone-fold protein CHRAC15chromatin accessibility complex 15 kDa proteinHuCHRAC15
02

Mechanism of action

Not currently targeted by specific approved drugs. Hypothetical mechanism: inhibition could suppress oncogenic transcription programs (specifically via modulation of YAP-dependent transcription in the Hippo pathway).

03

Biological functions

Chromatin remodelingNucleosome positioningRegulation of chromatin accessibilityRegulation of gene expressionDNA transcriptionDNA replicationDNA packaging
04

Disease associations

Cancer (including breast, cervical, ovarian, lung)Neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesOther: potential roles in brain-specific gene regulation and imprinting
05

Safety considerations

Potential challenge: Targeting chromatin remodelers can impact fundamental cellular processes (transcription, replication), raising risks of off-target toxicity in normal cells.Functional redundancy within chromatin remodeling complexes may reduce efficacy or complicate selectivity of any hypothetical inhibitors.
06

Biomarkers

Elevated CHRAC1 expression associated with poor prognosis in breast and cervical cancer; may serve as a prognostic biomarker for survival, pathological stage, and metastasis.Expression level correlation with resistance to cisplatin in ovarian cancer cell lines.

Beyond the preview

Go deeper on Chromatin accessibility complex protein 1 (CHRAC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromatin accessibility complex protein 1 (CHRAC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call